pelacarsen (AKCEA-APO(a)-LRx) - Novartis
Pelacarsen Roll-over Extension Program (clinicaltrials.gov) - Oct 15, 2026 - P3 | N=599 | Active, not recruiting | Sponsor: Novartis Pharmaceuticals | Recruiting ➔ Active, not recruiting 
Enrollment closed • Atherosclerosis • Cardiovascular
http://clinicaltrials.gov/ct2/show/NCT06875973
 
Oct 15, 2026
 
Prev Next